Lenacapavir Vardenafil

Sunlenca Product Label

Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects

Increased risk of vardenafil adverse effects (e.g. flushing, headache, hypotension)

Management

If co-administering vardenafil for erectile dysfunction, dose should not exceed 5 mg per 24 hour. Monitor for adverse effects.